Navigation Links
Rigel Announces Participation at Two Investor Conferences
Date:2/23/2012

SOUTH SAN FRANCISCO, Calif., Feb. 23, 2012 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, chairman and chief executive officer, and Ryan Maynard, executive vice president and chief financial officer of Rigel, will participate at two upcoming investor conferences. Details of the events are as follows:

(Logo:  http://photos.prnewswire.com/prnh/20030226/RIGLLOGO)

Citi 2012 Global Health Care Conference
Date: Monday, February 27 at 1:30 p.m. ET
Location: New York, NY
Presenter – Ryan Maynard

32nd Annual Cowen and Company Health Care Conference
Date: Monday, March 5 at 1:30 p.m. ET
Location: Boston, MA
Presenter – James M. Gower

Both events will be webcast live and can be accessed at www.rigel.com.  Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software download that may be necessary.

About Rigel (www.rigel.com)

Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. Rigel's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market its product candidates. Current product development programs include fostamatinib, an oral SYK inhibitor that is in Phase 3 clinical trials for rheumatoid arthritis, R343, an inhaled SYK inhibitor that has completed Phase 1 clinical trials for asthma, R548, an oral JAK3 inhibitor for the treatment of transplant rejection and other immune disorders, and R333, a topical JAK/SYK inhibitor for the treatment of discoid lupus.

Contact: Ryan Maynard
Phone: 650.624.1284
Email: invrel@rigel.com


'/>"/>
SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Rigel Announces Initiation of Clinical Trials in Two Immunology Programs
2. Rigel to Present at Oppenheimer Annual Healthcare Conference
3. Rigel Announces Third Quarter 2011 Financial Results
4. Rigel to Present at Two Upcoming Investor Conferences
5. Rigel to Present at Wells Fargo Securities Healthcare Conference
6. Rigel to Present at Jefferies Global Healthcare Conference
7. Rigel Announces Pricing of Public Offering of Common Stock
8. Rigel Announces Proposed Public Offering of Common Stock
9. Rigel to Present at Bank of America Merrill Lynch Health Care Conference
10. Rigel Announces First Quarter Financial Results
11. Rigel Announces Fourth Quarter and Year End 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... 6, 2016 Homozygous Familial Hypercholesterolemia ... Summary Global Markets Direct,s latest Pharmaceutical ... Hypercholesterolemia (HoFH) – Pipeline Review, H2 2016, ... Hypercholesterolemia (HoFH) (Metabolic Disorders) pipeline landscape. ... which is caused due to mutation from ...
(Date:12/6/2016)... Colo. , Dec. 6, 2016   ... of cartilage, cellular, bone, skin and soft-tissue allografts ... Meyer , Business Process Manager, for being named ... Malcolm Baldrige National Quality Award by the Commerce ... deepening the organization,s commitment to process excellence. The ...
(Date:12/6/2016)... 2016 Two new disaster drones delivered telemedical ... mass casualty event Tuesday at John Bell Airport in ... before an audience including Mississippi ... Security, Federal Law Enforcement Agencies, and the United Nations. ... (Health Integrated Rescue Operations), was developed by Italo ...
Breaking Medicine Technology:
(Date:12/7/2016)... , ... December 07, 2016 , ... ... consultation services from offices located in South Lyon, Dewitt, Williamston, East Lansing, Ann ... basketball coach who needs treatment for a brain tumor. , Jason Bauer and ...
(Date:12/7/2016)... ... December 07, 2016 , ... One of two inventors from Glen Burnie, Md., ... painful for her. "This is why the co-inventor and I have designed a new ... then created a prototype of the patent-pending AV-AIR, a device that serves as an ...
(Date:12/7/2016)... ... XX, 2016 (PRWEB) (PRWEB) December 07, 2016 , ... Man’s ... Filamentous Dermatitis Associated with Borrelia Infection” reveals that a condition similar ... the prestigious Journal of Veterinary Science & Medical Diagnosis. , Morgellons disease is ...
(Date:12/7/2016)... ... December 07, 2016 , ... Facial plastic surgeon, Dr. John D. Rachel ... a portion of proceeds to two local organizations: North Chicago Animal Control and Friends ... is a team of authorized and trained volunteers who support rescued animals held ...
(Date:12/7/2016)... ... December 07, 2016 , ... 1105 Media’s Live ... the Folio: Marketing Awards competition. Live From won in the Use of Social ... and ultimately successful projects undertaken by the media industry’s most innovative marketing professionals. ...
Breaking Medicine News(10 mins):